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The limited solubility, and therefore bioavailability, of the antimycotic drug, 
itraconazole, used for the treatment of intestinal Candidiasis in immunocompromised 
individuals, has been well documented. Therapeutic regimen in these patients may 
include daily administration of multiple doses of various drugs.  Hence, improving the 
residence time of therapeutic agents, would ensure a high continuous concentration in 
the body and help decrease the dosing frequency. In our current study, we have 
investigated a novel method of drug delivery, developed by utilizing the concept of 
mucoadhesiveness, for the sustained release of the drug, itraconazole. Mucoadhesive 
beads were prepared using two natural polymers, isabghula husk and alginate. The 
minimum inhibitory concentration of itraconazole for Candida was found to be 
1.5milligram per millilitre. Accordingly, beads were prepared by ionic gelation method 
using calcium chloride as a crosslinking agent. Marked improvement in solubility of the 
drug was noted after entrapment. Prepared beads were subjected to various evaluations 
including particle size, swelling behaviour and mucoadhesivity. At pH 7.4, good 
mucoadhesive property was exhibited up to 7 hours. Maximum swelling of beads was 
observed at 4hours in phosphate buffer after which the beads showed slight erosion. 
Fresh cock intestinal mucosa was used to assess the sustained release of itraconazole 
from the drug loaded beads and the reduction in candidal cells adhering to the mucosa 
was verified by the viable count technique. The results of our present study indicate that 
mucoadhesive intestinal retentive isabghula- alginate beads could represent a promising 
vehicle for drug delivery and help improve therapeutic efficacy and patient compliance 
in the future.    
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Candida albicans is a yeast that 
constitutes the normal flora of the human 
gastrointestinal tract. However, 
disequilibrium of the microbiota and 
dysregulation of the immune system in 
immunocompromised patients such as 
bone marrow transplant recipients and 
patients with acquired immunodeficiency 
syndrome (AIDS), favours the growth of 
these opportunistic microorganisms. The 
incidence of gastrointestinal Candida 
infections has increased in Human 
immunodeficiency virus (HIV) infected 
patients in the last two decades 
(Ghannoum et al, 2001). Patients with HIV 
infection are most likely to develop 
candidiasis after their CD4 counts have 
dropped to below 200 cells per cubic 
millimetre. Prophylactic antifungal agents 
like itraconazole can prevent the 
development of these infections. The 
management of HIV infection along with 
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other opportunistic diseases involves daily 
administration of multiple drug dosages. 
This is of particular concern, since the 
intensive therapeutic regimen followed by 
these patients is time consuming and 
cumbersome. The aim of our investigation 
was to explore a drug delivery system for 
the sustained release of itraconazole, in 
HIV infected patients suffering from 
intestinal candidiasis, utilizing the concepts 
of mucoadhesiveness. Our study describes 
the formulation and evaluation of 
intestinal-mucoadhesive beads of alginate 
containing the anti-fungal agent 
itraconazole, employing isabghula as a 
mucoadhesive material. 
Isabghula or psyllium (Plantago 
ovate Forsk.) is an important ayurvedic herb 
belonging to the Plantaginaceae family. Its 
seeds and husk are used for medicinal 
purposes. The seeds of isabghula contain 
mucilage (10-12%), fatty oil and large 
quantities of albuminous matter which is a 
pharmacologically inactive glucoside 
(Chevallier, 1996). Psyllium seed husk 
(PSH) consists of a xylan backbone with (1-
3) and (1-4) ß-D linkages and is highly 
substituted with arabinose / aldobiouronic 
acid residues (Prajapati et al, 2008). It is a 
partially fermented dietary fiber that 
increases stool weight and promotes 
laxation (Prynne  et al, 1979; Spiller  et al, 
1979). Many studies have documented the 
cholesterol reducing and glycemic response 
properties of psyllium husk containing 
foods (Guido et al, 2004).Thermally and 
acid treated husk has also been used as a 
superdisintegrant in many formulations. 
Formulations of mucoadhesive 
polymers are of current interest in the 
design of drug delivery systems. Current 
uses of mucoadhesive based preparations 
include ophthalmic solutions, local 
applications to treat diseases, protein and 
peptide delivery etc. (Malaekeh-Nikouei et 
al, 2008).  A few previous investigations 
have demonstrated the mucoadhesive 
properties of isabghula to membranes 
(Nayak et al, 2010) due to its high mucilage 
content suggesting it as a suitable carrier 
for sustained drug release. PSH can swell 
and form a white, fibrous gel by absorbing 
water and can get attached to mucus 
linings by forming bonds on their surface. 
This helps to provide a more controlled and 
a sustained release profile of drug delivery 
than possible by conventional methods. It is 
hypothesized that the increased 
bioavailability of the drug for a longer time 
results due to a higher flux generated by 
the intimate contact between the surfaces of 
the mucosal layer and the pharmacoactive 
compound. 
Alginates are natural 
polysaccharides obtained from brown algae 
and can be considered as block polymers 
consisting of mannuronic acid, guluronic 
acid, and mannuronic acid‐guluronic acid. 
They are hemocompatible and do not 
accumulate in any organ of the body. They 
have also been used as matrix material in 
medicine to achieve controlled drug 
delivery due to their hydrogel forming 
properties. Although alginates also have 
mucoadhesive properties, its beads are 
usually fragile (George et al, 2006; Sandhu 
et al, 1981) and can be strengthened by 
incorporation of isabghula husk in the 
formulation. Itraconazole is hydrophobic in 
nature and its absorption rate in the 
gastrointestinal tract is slow due to poor 
dissolution. Inclusion of itraconazole in 
cross-linked isabghula-alginate beads 
would help to overcome this difficulty and 
improve biosorption. 
In our present investigation we 
have tested the two main criteria important 
for a successful formulation- mucoadhesion 
to retain the antibiotic on the surface of the 
gastric mucosa and sustained activity of the 
released drug. 
 
Materials and methods  
Culture & growth conditions  
Candida albicans culture obtained 
from a local hospital was grown overnight 
at 37oC in Sabouraud’s broth to obtain cells 
in budding phase. Cells were harvested, 
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washed in sterile saline and standardized to 
an O.D. of 0.1 at 530nm (Erma Inc.). 
The antifungal agent, itraconazole 
(ITZ) used in this study was procured from 
Johnson & Johnson (Mumbai). Ispaghula 
husk was purchased from a local market 
(Telephone Brand, Gujarat) and sodium 
alginate from S.D.Fine Chemicals, Mumbai. 
All other chemicals used were of analytical 
grade. 
 
Determination of minimum inhibitory 
concentration of Itraconazole against C. 
albicans 
Using stock solution of itraconazole 
(10mg/ml) various dilutions were 
prepared. 0.1 ml of the 48 hour old 
C.albicans culture was added to all the 
tubes. Positive and negative controls were 
maintained. Tubes were incubated at 37oC 
for 48 hour and the lowest concentration 
that did not show growth corresponded to 
the minimum inhibitory concentration 
(MIC). 
 
Preparation of alginate-isabghula beads 
loaded with itraconazole 
Alginate-isabghula beads 
containing itraconazole were prepared by 
employing the ionotropic gelation method 
using calcium chloride (CaCl2) as a counter 
ion (Hudson et al, 1995). Dispersions of 
sodium alginate and isabghula were 
prepared separately in distilled water. Both 
dispersions were homogenized with a 
magnetic stirrer. The active substance, 
itraconazole, was added to the isabghula 
dispersion. Drug concentration was 
maintained according to the MIC of 
itraconazole for Candida. Both the 
dispersions were then mixed in a ratio of 
1:1 and stirred at 1000 rpm for 10 minutes. 
The resulting dispersion was then added 
via a gauze needle (no. 23) into agitated 
CaCl2 solutions (6 and 7% w/v 
concentration). The resultant beads were 
retained in the CaCl2 solution for 20 
minutes to complete the curing reaction 
and to produce spherical rigid beads. Beads 
were collected by decantation and washed 
with deionized water. Drug loaded beads 
were dried in a hot air oven at 40 °C for 48 
hours. 
 
Drug entrapment 
50 mg of beads were accurately 
weighed and dispensed in 100 ml of 
phosphate buffer pH 7.4 and kept for 48 h 
at 37°C with occasional shaking. The 
polymer debris formed after disintegration 
of the beads was removed by filtering 
through Whatmann filter paper (No. 40). 
The drug content in the filtrate was 
determined using a UV-Vis 
spectrophotometer (Helios- alpha) at 274 
nm. 
 
Particle size measurement 
To determine the particle size of 
itraconazole-loaded beads, 100 dry beads 
were measured using an optical microscope 
(Leitz Wetzlar, Germany) with an ocular 
micrometer. 
 
Mucoadhesion testing by in vitro wash-
off method 
In order to check the mucoadhesive 
property of the beads, in vitro wash-off 
method was used. (Sharma et al, 2009; 
Prajapati  et al, 2008). Freshly excised pieces 
of cock intestinal mucosa (1 cm x 1 cm) 
were mounted on a glass slide using 
cyanoacrylate glue. About 50 beads were 
spread out on each piece of mucosa and 
suspended in a 500ml vessel containing 900 
ml phosphate buffer (pH 7.4) maintained at 
37°C. The tissue specimen was given a 
regular up and down movement, to 
simulate a tablet disintegrator, and the 
adherence of beads was regularly observed. 
The beads that remained adhered to the 
mucosa were counted upto 10 hours at 
regular intervals. 
 
Evaluation of swelling behaviour 
Swelling behaviour was studied by 
measuring the percentage water uptake by 
the beads which is also known as swelling 
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index. Accurately weighed beads were 
placed in 50 ml of phosphate buffer (pH 
7.4) and 0.1 N HCl (pH 1.2). Beads were 
removed from their respective swelling 
media after intervals of 1 hour and weighed 
after drying the surface water using filter 
paper. The water uptake was calculated as 
follows: 
Swelling Index= W1 – W2x 100 
                                  W2 
where, 
W1= Weight of beads after swelling 
W2=Weight of dry beads 
 
Antifungal activity of the isabghula-
alginate beads 
To study the antifungal activity of 
the prepared beads, 0.1 ml of Candida 
culture (adjusted to OD 0.03) was added to 
several small pieces of cock intestinal 
mucosa (1cm x 1cm) and allowed to adhere 
for 24hours. These pieces were then washed 
with phosphate buffer (pH7.4) and treated 
with ITZ-loaded beads for different time 
intervals. Viable count of candidal cells was 
determined by suspending and vortexing 
the mucosal pieces in sterile saline, 
followed by plating on modified Malt 
extract agar containing penicillin, 
streptomycin and potassium tellurite. 
Plates were incubated at 37oC for 48 hours 
and colonies counted.  Controls were 
maintained and consisted of sets of 
intestinal tissue treated with Candida 
culture but not exposed to ITZ-loaded 
beads. All experiments were performed in 
triplicate and repeated three times. Mean 
values have been reported. 
 
Results 
The minimum inhibitory 
concentration of itraconazole for Candida 
was found to be 1.5 milligrams per millilitre 
by the macro-broth dilution method. 
Hence, this concentration was selected for 
incorporation in the ispaghula 
husk‐sodium alginate beads, prepared by 
ionic gelation method. Beads formed were 
spherical, free flowing and cream in colour. 
The drug content entrapped was found to 
be 1.9 mg per 50mg beads. Their average 
diameter was between 0.89- 0.97millimeter, 
while the ideal concentration of CaCl2 for 
formation of rigid beads was determined to 
be 7%.  
The swelling behaviour of 
mucoadhesive polymeric beads is one of 
the major factors controlling the release of 
the drug from them. 
 
Figure 1: Swelling Index of isabghula-
alginate beads containing itraconazole in 
phosphate buffer and HCl at intervals of 
one hour. 
 
Table 1: Mucoadhesivity of isabghula- 
alginate beads at different time intervals. 
Time (Hours) Percentage of beads 
(%) 
0 100 
1 96±1.6 
2 82±2.4 
3 78±1.1 
4 72±1.2 
5 60±1.8 
6 46±1.2 
7 36±1.2 
8 - 
9 - 
10 - 
  
Suparna Dugal & Andrea Fernandes / Research in Pharmacy 1(4) : 10-16, 2011    
 
 
14 
 
Table 2: Viable count of candidal cells adhered to mucosal surface at different time intervals
 
 
 
0 hour 
 
2hours 
 
5hours 
 
18 hours 
 
Test 
 
1.9x 109 
 
2.1x105 
 
1.2x 103 
 
No growth 
 
Control 
 
1.7x109 
 
2.9x109 
 
4.1x 107 
 
1.5x 107 
 
In vivo, swelling of the beads would occur 
during their transit through the 
gastrointestinal tract, that is, first in the 
stomach and then in the intestine. For this 
reason, the swelling behaviour of ITZ-
loaded alginate-ispaghula beads was 
evaluated in hydrochloric acid as well as in 
phosphate buffer (representing the pH of 
stomach and intestine respectively) at 
various time intervals. Maximum swelling 
of the capsules was noticed at 4hours in 
phosphate buffer, after which the beads 
showed a slight erosion. Figure 1 shows the 
increase in the swelling index (S.I.) with 
time. Mucoadhesivity studies were 
performed by assessing the degree of 
adherence of the beads to pieces of 
intestinal mucosa in the presence of 
phosphate buffer (pH 7.4).Our results 
(Table 1) showed adherence of 36% of the 
beads upto 7 hours following which 
complete disintegration of the capsules 
occurred. Viable count of candidal cells, 
determined by the surface spread technique 
revealed small black colonies on plates after 
48 hours. A 10,000-fold decrease in the 
number of viable cells was evident after 
exposure to the drug loaded beads for 2 
hours. Complete killing of all the yeast cells 
was noted in 18 hours. The result of viable 
count of yeast cells, at different time 
intervals, is shown in Table 2. 
 
Discussion 
In the last few decades there has 
been an explosion in the number of 
technologies available to control drug 
distribution and bioavailability (Bajaj  et al, 
2006; Pillai et al, 2011).   However, there is 
still need for further research to develop 
novel drug delivery systems (NDDS) which 
can improve therapeutic efficacy and 
decrease the dosing frequency during 
antimicrobial therapy. In this paper, we 
have focused on improving the drug 
bioavailability and hence patient 
compliance in HIV-infected individuals 
suffering from intestinal candidiasis, by 
itraconazole. Itraconazole was selected as a 
drug of choice since resistance has emerged 
to fluconazole, the primary azole antifungal 
agent being used to treat Candida infections. 
Also other negative aspects of fluconazole, 
like drug toxicity and interactions, make 
itraconazole a far more suitable choice for 
prophylaxis and treatment for fungal 
infections of the gastrointestinal tract. 
Itraconazole inhibits fungal cytochrome 
P450 oxidase leading to impaired ergosterol 
metabolism. Studies have also shown it to 
modify the cell wall of Candida and provoke 
defective separation between mother and 
daughter yeast cells (Bastide et al. 1987). 
Itraconazole has relatively low 
bioavailability after oral administration, 
especially when given in capsule form on 
an empty stomach. In our current study we 
found that entraption of itraconazole in 
isabghula beads helped to increase its 
solubility, which would thus serve to 
increase its biosorption and residence time 
in the intestine. 
The isabghula-alginate capsules 
exhibited good mucoadhesive property in 
the in vitro test. Drug release from the ITZ 
loaded beads was slow as adhesion to 
intestinal mucosa extended over an 8 hour 
period at pH 7.4. Mucoadhesion occurred 
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due to swelling of the natural polymers 
isabghula and alginate at an alkaline pH of 
the gut, followed by diffusion of the 
hydrophilic groups of these polymers into 
the mucosal layer. Strong secondary bond 
formation resulted in stable mucoadhesion 
for a long time, helping in sustained drug 
delivery until the beads underwent erosion. 
(Mohammed et al, 2010). Our results of 
mucoadhesion testing are in agreement 
with studies by previous investigators who 
have employed isabghula as a 
mucoadhesive polymer for delivery of 
glucose lowering agents, metformin 
hydrochloride and gliclazide (Sharma  et al, 
2008; Prajapati et al, 2008). To our 
knowledge, this is the first study to explore 
the use of isabghula as a mucoadhesive 
agent to enhance the delivery of an 
antimicrobial agent to the intestine for 
treating a mycotic infection. Theresults of 
viable count of cells show itraconazole as a 
very effective drug to control candidiasis. 
Conventionally, itraconazole dosages are 
administered daily, after a 12 hour interval. 
Our results show mucoadhesive beads 
could eliminate all viable cells even up to 
18 hours, thus indicating that this mode of 
drug delivery could greatly help in 
decreasing the dosing frequency in a 
patient. The 100 fold decrease in number of 
viable candidal cells in the control after 18 
hours, could probably be due to the 
absence of sugars which could have served 
as a nutrient source on the mucosal tissue. 
In vivo, the dietary intake of sugars and 
carbohydrates by an individual would 
ensure that such a decrease in the 
population of viable cells would be unlikely 
to occur without the administration of an 
antimycotic agent. 
 
Conclusion 
Today the field of developing novel 
techniques of drug delivery  represents a 
major research and development focus 
area, in view of  the manifold therapeutic 
benefits which can be availed of by 
patients. The development of intestinal 
controlled release formulations continues to 
be one of the greatest challenges in the 
pharmaceutical industry due to the 
vagaries of the gastrointestinal 
environment. 
Drug loaded beads, prepared using 
alginate and psyllium husk, both natural 
polymers, were found to be efficient with 
respect to swelling ratio, mucoadhesion 
and antifungal activity. Hence, our 
investigation indicates the potential benefit 
of using isabghula as a mucoadhesive agent 
for intestinal controlled release of 
antimycotic itraconazole for the treatment 
of intestinal candidiasis in HIV infected 
patients. Further in vivo tests and clinical 
trials would validate the usefulness of this 
approach and lead to the introduction of a 
novel mode of therapeutic delivery. 
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